posted on 18.05.2020, 11:45by S Seidu, J Barrat, K Khunti
Diabetic kidney disease (DKD) is common complication of type 1 and type 2 diabetes and may lead to progressive kidney dysfunction culminating in end-stage kidney disease. Kidney function is evaluated less frequently than other care procedures in patients with diabetes, even though the opportunity to identify DKD early and slow or even halt renal damage early in the disease progression represents a potentially important clinical opportunity for early intervention. The following review provides an overview of the under-recognised importance of kidney function in T2D and current best-practice to support the identification of DKD as part of primary care T2D management.
KK and SIS acknowledge support from the NIHR Collaboration for Leadership in Applied Health Research and Care East Midlands (CLAHRC EM) and the NIHR Leicester, Biomedical Research Centre. Medical writing services were provided on behalf of the authors by Amisten Consulting. Support for this assistance was funded by Napp Pharmaceuticals Limited. Napp has not been involved in the creation of the content for this review article and has reviewed the document for factual accuracy only. All authors had full access to the articles reviewed in this manuscript and take full responsibility for the integrity and accuracy of this manuscript. The Fee for the submission was funded by Napp Pharmaceuticals Limited.